Mij
Senior Member (Voting Rights)
Beyond sleep aid: How melatonin research could transform sleep and pain therapies
"When sleep problems arise, many people turn to melatonin supplements, which mimic the body’s naturally occurring sleep hormone, but their effects are modest. Neuroscientists like Dr. Gabriella Gobbi at McGill University are now uncovering that melatonin acts through a complex system in the brain.
At the center of this complex system are two receptors known as MT1 and MT2. Think of them as “locks” that melatonin, the “key”, binds to in order to affect sleep. “Sleep depends on where and how these two melatonin receptors are activated,” Dr. Gobbi explains.
At the center of this complex system are two receptors known as MT1 and MT2. Think of them as “locks” that melatonin, the “key”, binds to in order to affect sleep. “Sleep depends on where and how these two melatonin receptors are activated,” Dr. Gobbi explains."
"Dr. Gobbi’s work also shows that activating these receptors individually could optimize specific sleep stages. What happens when both receptors are activated at once? The benefits may cancel out, Dr. Gobbi explains, highlighting the importance of selectively targeting a single receptor.
Her team also developed experimental drugs designed to selectively activate either MT1 or MT2 receptors. A study in animal models showed that an MT1-targeting compound activated specific brain regions resulting in increased REM sleep."
Pre-clinical studies show that targeting specific melatonin receptors—proteins activated by melatonin in the brain—may lead to promising treatments for sleep disorders and chronic pain
"When sleep problems arise, many people turn to melatonin supplements, which mimic the body’s naturally occurring sleep hormone, but their effects are modest. Neuroscientists like Dr. Gabriella Gobbi at McGill University are now uncovering that melatonin acts through a complex system in the brain.
At the center of this complex system are two receptors known as MT1 and MT2. Think of them as “locks” that melatonin, the “key”, binds to in order to affect sleep. “Sleep depends on where and how these two melatonin receptors are activated,” Dr. Gobbi explains.
At the center of this complex system are two receptors known as MT1 and MT2. Think of them as “locks” that melatonin, the “key”, binds to in order to affect sleep. “Sleep depends on where and how these two melatonin receptors are activated,” Dr. Gobbi explains."
"Dr. Gobbi’s work also shows that activating these receptors individually could optimize specific sleep stages. What happens when both receptors are activated at once? The benefits may cancel out, Dr. Gobbi explains, highlighting the importance of selectively targeting a single receptor.
Her team also developed experimental drugs designed to selectively activate either MT1 or MT2 receptors. A study in animal models showed that an MT1-targeting compound activated specific brain regions resulting in increased REM sleep."